Drugs for the circuit-based human

mindhacks.com - In a recent article for The Observer I noted that almost all the major drug companies had closed down their neuroscience divisions as evidence for a move away from a ‘chemical-based’ to a ‘circuit-based’ approach to treatments.So to my surprise, a new Nature News article has just appeared discussing the re-launch of pharmaceutical giant Novartis’s neuroscience section.However, as I read the beginning of the article, it seems they are just banking on the fact that they can design drugs good enough to hit individual brain circuits.